Tuberculosis in Pregnancy

Obstet Gynecol. 2020 Jun;135(6):1444-1453. doi: 10.1097/AOG.0000000000003890.


Tuberculosis (TB) in pregnancy poses a substantial risk of morbidity to both the pregnant woman and the fetus if not diagnosed and treated in a timely manner. Assessing the risk of having Mycobacterium tuberculosis infection is essential to determining when further evaluation should occur. Obstetrician-gynecologists are in a unique position to identify individuals with infection and facilitate further evaluation and follow up as needed. A TB evaluation consists of a TB risk assessment, medical history, physical examination, and a symptom screen; a TB test should be performed if indicated by the TB evaluation. If a pregnant woman has signs or symptoms of TB or if the test result for TB infection is positive, active TB disease must be ruled out before delivery, with a chest radiograph and other diagnostics as indicated. If active TB disease is diagnosed, it should be treated; providers must decide when treatment of latent TB infection is most beneficial. Most women will not require latent TB infection treatment while pregnant, but all require close follow up and monitoring. Treatment should be coordinated with the TB control program within the respective jurisdiction and initiated based on the woman's risk factors including social history, comorbidities (particularly human immunodeficiency virus [HIV] infection), and concomitant medications.

Publication types

  • Review

MeSH terms

  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / therapeutic use
  • Female
  • HIV Infections / epidemiology
  • Humans
  • Latent Tuberculosis / diagnosis
  • Latent Tuberculosis / drug therapy
  • Pregnancy
  • Pregnancy Complications, Infectious
  • Risk Factors
  • Tuberculosis / diagnosis*
  • Tuberculosis / drug therapy*


  • Antitubercular Agents